ES8506902A1 - Un procedimiento para la purificacion de un antigeno. - Google Patents
Un procedimiento para la purificacion de un antigeno.Info
- Publication number
- ES8506902A1 ES8506902A1 ES528000A ES528000A ES8506902A1 ES 8506902 A1 ES8506902 A1 ES 8506902A1 ES 528000 A ES528000 A ES 528000A ES 528000 A ES528000 A ES 528000A ES 8506902 A1 ES8506902 A1 ES 8506902A1
- Authority
- ES
- Spain
- Prior art keywords
- antigen
- antibody
- environment
- monoclonal antibodies
- affinity purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000001261 affinity purification Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 6
- 102000036639 antigens Human genes 0.000 abstract 6
- 108091007433 antigens Proteins 0.000 abstract 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 230000002427 irreversible effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCEDIMIENTO PARA LA PURIFICACION DE UN ANTIGENO.COMPRENDE: A) SELECCIONAR UN ANTICUERPO QUE TIENE UNA GRAN AFINIDAD POR EL ANTIGENO EN UN PRIMER MEDIO AMBIENTE Y UNA BAJA AFINIDAD POR EL ANTIGENO EN UN SEGUNDO MEDIO AMBIENTE, SIN QUE NINGUNO DE LOS MEDIOS AMBIENTES ALTERE DE MODO SUSTANCIALMENTE IRREVERSIBLE LAS PROPIEDADES INMUNOQUIMICAS O BIOLOGICAS DEL ANTIGENO O DEL ANTICUERPO; B) INMOVILIZAR EL ANTICUERPO SOBRE UN SOPORTE SOLIDO; C) FIJAR EL ANTIGENO AL ANTICUERPO EN EL PRIMER MEDIO AMBIENTE, CONSISTENTE EN UN LIQUIDO A UN PH DETERMINADO; D) SEPARAR LAS IMPUREZAS NO FIJADAS DEL ANTIGENO FIJADO, Y E) ELUIR EL ANTIGENO EN UNA FORMA PURIFICADA DESDE EL ANTICUERPO INMOVILIZADO, UTILIZANDO COMO ELUYENTE EL SEGUNDO MEDIO AMBIENTE, CONSISTENTE EN UNA SOLUCION QUE CONTIENE AGENTES CAOTROPICOS SELECCIONADOS ENTRE BRK, KI Y GUANIDINA Y UN PH ENTRE 4 Y 10,5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36778182A | 1982-04-12 | 1982-04-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8506902A1 true ES8506902A1 (es) | 1985-08-01 |
ES528000A0 ES528000A0 (es) | 1985-08-01 |
Family
ID=23448565
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521371A Expired ES8404858A1 (es) | 1982-04-12 | 1983-04-11 | Un procedimiento para la purificacion de un anticuerpo. |
ES528000A Granted ES528000A0 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para la purificacion de un antigeno. |
ES528001A Expired ES8706964A1 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para fraccionar anticuerpos de suero. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521371A Expired ES8404858A1 (es) | 1982-04-12 | 1983-04-11 | Un procedimiento para la purificacion de un anticuerpo. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES528001A Expired ES8706964A1 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para fraccionar anticuerpos de suero. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0105359A4 (es) |
AT (1) | AT393386B (es) |
AU (1) | AU622099B2 (es) |
CA (1) | CA1209907A (es) |
CH (1) | CH672028A5 (es) |
DK (1) | DK192191A (es) |
ES (3) | ES8404858A1 (es) |
FI (1) | FI88403C (es) |
GB (1) | GB2128630B (es) |
IT (1) | IT1219779B (es) |
WO (1) | WO1983003678A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8328918D0 (en) * | 1983-10-28 | 1983-11-30 | Unilever Plc | Alkaline phosphatase |
GB8331071D0 (en) * | 1983-11-22 | 1983-12-29 | Karayiannis P | Assay for dna/rna |
US4666865A (en) * | 1984-01-13 | 1987-05-19 | Centocor, Inc. | Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies |
US4789631A (en) * | 1984-02-17 | 1988-12-06 | Synbiotics Corporation | Immunoassay for anti-dirofilaria immitis antibody |
GB8426468D0 (en) * | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
AU5259786A (en) * | 1985-01-30 | 1986-08-07 | United States Of America, The | Monoclonal antibodies against chlamydial genes specific lipopolysaccharide |
US4818687A (en) * | 1985-02-28 | 1989-04-04 | Massachusetts Institute Of Technology | Affinity column and process for detection of low molecular weight toxic substances |
US4859611A (en) * | 1985-02-28 | 1989-08-22 | Massachusetts Institute Of Technology | Affinity column and process for detection of low molecular weight toxic substances |
IL75828A (en) * | 1985-07-17 | 1991-06-10 | Univ Ramot | Immobilization by biologically active proteins |
NZ218336A (en) * | 1985-12-09 | 1991-08-27 | Kirin Amgen Inc | Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf) |
US5175255A (en) * | 1987-03-23 | 1992-12-29 | Amgen Inc. | Methods for purification of platelet-derived growth factor |
US5190859A (en) * | 1987-02-26 | 1993-03-02 | Dana-Farber Cancer Institute, Inc. | Purification of LFA-3 |
SE468653B (sv) * | 1987-03-06 | 1993-02-22 | Perstorp Biolytica | Adsorbent foer isokratisk affinitetskromatografi |
JPS6463599A (en) * | 1987-05-01 | 1989-03-09 | Xoma Corp | Purification of immunoglobulin by selective anti-idiotype bond |
ATE76974T1 (de) * | 1987-07-14 | 1992-06-15 | Univ Manchester | Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden. |
CA1323567C (en) * | 1987-10-05 | 1993-10-26 | Gene R. Nathans | Method for purification of antibodies |
US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
JP2001515345A (ja) * | 1996-09-20 | 2001-09-18 | ザ・ジェネラル・ホスピタル・コーポレイション | アルファ―2―抗プラスミンに対する抗体を用いてフィブリン溶解を増進するための組成物と方法 |
TWI564021B (zh) * | 2008-04-11 | 2017-01-01 | Chugai Pharmaceutical Co Ltd | Repeated binding of antigen to antigen binding molecules |
MX365235B (es) | 2010-11-30 | 2019-05-28 | Chugai Pharmaceutical Co Ltd | Molécula de unión a antígeno capaz de unir repetidamente a la pluralidad de moléculas de antígeno. |
US20140093496A1 (en) | 2011-02-25 | 2014-04-03 | Chugai Seiyaku Kabushiki Kaisha | Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY |
US20150050269A1 (en) | 2011-09-30 | 2015-02-19 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
US20150056182A1 (en) | 2011-11-30 | 2015-02-26 | Chugai Seiyaku Kabushiki Kaisha | Drug containing carrier into cell for forming immune complex |
CN113045650A (zh) | 2014-12-19 | 2021-06-29 | 中外制药株式会社 | 抗-c5抗体及使用方法 |
CA2963760A1 (en) | 2014-12-19 | 2016-06-23 | Yoshinao Ruike | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use |
EP3394098A4 (en) | 2015-12-25 | 2019-11-13 | Chugai Seiyaku Kabushiki Kaisha | ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE |
CA3026050A1 (en) | 2016-08-05 | 2018-02-08 | Chugai Seiyaku Kabushiki Kaisha | Composition for prophylaxis or treatment of il-8 related diseases |
JP7191833B2 (ja) | 2017-01-30 | 2022-12-19 | 中外製薬株式会社 | 抗スクレロスチン抗体およびその使用 |
CN110724204B (zh) * | 2019-11-18 | 2021-10-22 | 广东菲鹏制药股份有限公司 | Fc融合蛋白的纯化方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172124A (en) * | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
ATE14269T1 (de) * | 1981-02-26 | 1985-08-15 | Unilever Nv | Verfahren und vorrichtung zur rueckgewinnung von immunoglobulinen. |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
-
1983
- 1983-04-11 CA CA000425555A patent/CA1209907A/en not_active Expired
- 1983-04-11 ES ES521371A patent/ES8404858A1/es not_active Expired
- 1983-04-12 AT AT9019/83A patent/AT393386B/de not_active IP Right Cessation
- 1983-04-12 CH CH6699/83A patent/CH672028A5/de not_active IP Right Cessation
- 1983-04-12 IT IT20550/83A patent/IT1219779B/it active
- 1983-04-12 WO PCT/US1983/000524 patent/WO1983003678A1/en not_active Application Discontinuation
- 1983-04-12 EP EP19830901671 patent/EP0105359A4/en not_active Withdrawn
- 1983-04-12 GB GB08332644A patent/GB2128630B/en not_active Expired
- 1983-12-09 FI FI834530A patent/FI88403C/fi not_active IP Right Cessation
- 1983-12-13 ES ES528000A patent/ES528000A0/es active Granted
- 1983-12-13 ES ES528001A patent/ES8706964A1/es not_active Expired
-
1987
- 1987-05-06 AU AU72569/87A patent/AU622099B2/en not_active Ceased
-
1991
- 1991-11-26 DK DK192191A patent/DK192191A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI88403C (fi) | 1993-05-10 |
CH672028A5 (es) | 1989-10-13 |
AU7256987A (en) | 1987-09-03 |
AT393386B (de) | 1991-10-10 |
IT1219779B (it) | 1990-05-24 |
FI834530A (fi) | 1983-12-09 |
GB8332644D0 (en) | 1984-01-11 |
IT8320550A0 (it) | 1983-04-12 |
ES521371A0 (es) | 1984-05-16 |
ES528001A0 (es) | 1987-07-01 |
ES8404858A1 (es) | 1984-05-16 |
WO1983003678A1 (en) | 1983-10-27 |
AU622099B2 (en) | 1992-04-02 |
ATA901983A (de) | 1991-03-15 |
FI834530A0 (fi) | 1983-12-09 |
GB2128630B (en) | 1986-08-28 |
ES8706964A1 (es) | 1987-07-01 |
EP0105359A1 (en) | 1984-04-18 |
CA1209907A (en) | 1986-08-19 |
FI88403B (fi) | 1993-01-29 |
DK192191D0 (da) | 1991-11-26 |
GB2128630A (en) | 1984-05-02 |
ES528000A0 (es) | 1985-08-01 |
EP0105359A4 (en) | 1984-08-20 |
DK192191A (da) | 1991-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8506902A1 (es) | Un procedimiento para la purificacion de un antigeno. | |
PT89889A (pt) | Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes | |
NZ191317A (en) | Immunological determination of immuno-complexes diagnostic agent | |
KR890701632A (ko) | 사람 인터루킨-4에 대한 모노클로날 항체 및 이를 생성하는 하이브리도마 | |
ATE51449T1 (de) | Immunchemisches messverfahren fuer haptene und proteine. | |
DK407987A (da) | Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer | |
KR850002385A (ko) | PIVKA-Ⅱ의 측정(assay)용 방법 및 시약 | |
DE58907087D1 (de) | Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz. | |
MY103022A (en) | Monoclonal antibodies recognizing l-thyroxine | |
ATE80467T1 (de) | Immuntestverfahren. | |
KR930004458A (ko) | 설폰화 중합체에 대한 모노클로날 항체 | |
FI86255B (fi) | Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes. | |
Zeheb et al. | An analytical method for the selective retrieval of iminobiotin-derivatized plasma membrane proteins | |
KR930004476A (ko) | 인자(xiii)의 정제방법, 인자(xiiia)에 대한 모노클로날 항체, 이의 제조방법 및 용도 | |
KR910018041A (ko) | Pp4에 대한 모노클로날 항체, 이의 제조방법 및 용도 | |
ES8401261A1 (es) | Soportes de materia plastica revestidos de un segundo anticuerpo. | |
EP0672685A3 (en) | Monoclonal antibody. | |
KR940005284A (ko) | 면역친화성 크로마토그래피에 의한 플라스미노겐 활성화제 억제제 2의 정제방법 | |
GR3023701T3 (en) | Process for selective removal of salivary alpha-amylase and assay for pancreatic alpha-amylase | |
KR950031110A (ko) | 인간 혈증 아포지단백질 비-100(b-100)에 대한 신규 단일클론 항체 및 이들의 생산을 위한 재조합 하이브리도마 세포주 | |
KR830005828A (ko) | 경쟁적 방사성면역시험법에서의 결합 및 분리방법 | |
ES8606499A1 (es) | Un procedimiento para la valoracion de la concentracion de inmunoglobulina e en sueros humanos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970505 |